DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy

OBJECTIVE: This study aimed to develop a new oral paclitaxel formulation (DHP23002) and to evaluate its absorption and antitumor effects in a pancreatic tumor mouse model. METHODS: To investigate the oral absorption of DHP23002, a newly developed lipid-based orally active paclitaxel formulation, a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Eunseo, Son, Minhee, Jang, Junhee, Lee, In-Hyun, Kim, Sol, Kwon, Taejun, Jeon, Yong-hyun, Koh, Woo-Suk, Kim, Kil-Soo, Kim, Sang Kyoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863550/
https://www.ncbi.nlm.nih.gov/pubmed/31743348
http://dx.doi.org/10.1371/journal.pone.0225095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863550/
https://www.ncbi.nlm.nih.gov/pubmed/31743348
http://dx.doi.org/10.1371/journal.pone.0225095

Ejemplares similares